Literature DB >> 33456973

Continuous flow synthesis of a pharmaceutical intermediate: a computational fluid dynamics approach.

Cameron T Armstrong1, Cailean Q Pritchard2, Daniel W Cook1, Mariam Ibrahim1, Bimbisar K Desai1, Patrick J Whitham3, Brian J Marquardt3, Yizheng Chen1, Jeremie T Zoueu1, Michael J Bortner2, Thomas D Roper1.   

Abstract

Continuous flow chemistry has the potential to greatly improve efficiency in the synthesis of active pharmaceutical ingredients (APIs); however, the optimization of these processes can be complicated by a large number of variables affecting reaction success. In this work, a screening design of experiments was used to compare computational fluid dynamics (CFD) simulations with experimental results. CFD simulations and experimental results both identified the reactor residence time and reactor temperature as the most significant factors affecting product yield for this reaction within the studied design space. A point-to-point comparison of the results showed absolute differences in product yield as low as 2.4% yield at low residence times and up to 19.1% yield at high residence times with strong correlation between predicted and experimental percent yields. CFD was found to underestimate the product yields at low residence times and overestimate at higher residence times. The correlation in predicted product yield and the agreement in identifying significant factors in reaction performance reveals the utility of CFD as a valuable tool in the design of continuous flow tube reactors with significantly reduced experimentation.
© 2019 The Royal Society of Chemistry.

Entities:  

Year:  2019        PMID: 33456973      PMCID: PMC7745113          DOI: 10.1039/c8re00252e

Source DB:  PubMed          Journal:  React Chem Eng            Impact factor:   4.239


  8 in total

1.  Applying flow chemistry: methods, materials, and multistep synthesis.

Authors:  D Tyler McQuade; Peter H Seeberger
Journal:  J Org Chem       Date:  2013-06-20       Impact factor: 4.354

2.  Kilogram-scale prexasertib monolactate monohydrate synthesis under continuous-flow CGMP conditions.

Authors:  Kevin P Cole; Jennifer McClary Groh; Martin D Johnson; Christopher L Burcham; Bradley M Campbell; William D Diseroad; Michael R Heller; John R Howell; Neil J Kallman; Thomas M Koenig; Scott A May; Richard D Miller; David Mitchell; David P Myers; Steven S Myers; Joseph L Phillips; Christopher S Polster; Timothy D White; Jim Cashman; Declan Hurley; Robert Moylan; Paul Sheehan; Richard D Spencer; Kenneth Desmond; Paul Desmond; Olivia Gowran
Journal:  Science       Date:  2017-06-16       Impact factor: 47.728

3.  Combination of CFD and DOE to analyze and improve the mass flow rate in urinary catheters.

Authors:  Patrick Frawley; Marco Geron
Journal:  J Biomech Eng       Date:  2009-08       Impact factor: 2.097

Review 4.  Continuous-flow technology—a tool for the safe manufacturing of active pharmaceutical ingredients.

Authors:  Bernhard Gutmann; David Cantillo; C Oliver Kappe
Journal:  Angew Chem Int Ed Engl       Date:  2015-05-18       Impact factor: 15.336

5.  The Hitchhiker's Guide to Flow Chemistry ∥.

Authors:  Matthew B Plutschack; Bartholomäus Pieber; Kerry Gilmore; Peter H Seeberger
Journal:  Chem Rev       Date:  2017-06-01       Impact factor: 60.622

Review 6.  Candidates for inclusion in a universal antiretroviral regimen: dolutegravir.

Authors:  Pedro Cahn
Journal:  Curr Opin HIV AIDS       Date:  2017-07       Impact factor: 4.283

7.  An efficient and highly diastereoselective synthesis of GSK1265744, a potent HIV integrase inhibitor.

Authors:  Huan Wang; Matthew D Kowalski; Ami S Lakdawala; Frederick G Vogt; Lianming Wu
Journal:  Org Lett       Date:  2015-01-23       Impact factor: 6.005

8.  7-Step Flow Synthesis of the HIV Integrase Inhibitor Dolutegravir.

Authors:  Robert E Ziegler; Bimbisar K Desai; Jo-Ann Jee; B Frank Gupton; Thomas D Roper; Timothy F Jamison
Journal:  Angew Chem Int Ed Engl       Date:  2018-05-14       Impact factor: 15.336

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.